[Sodium nitroprusside in centralized circulatory shock].
D000007:Abdominal Injuries / Q000188:drug therapy; D000062:Accidents, Occupational; D000328:Adult; D000818:Animals; D003444:Crush Syndrome / Q000188:drug therapy; D003486:Cyanides / Q000633:toxicity; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005292:Ferricyanides / Q000627:therapeutic use*; D000882:Haplorhini; D006801:Humans; D008297:Male; D009599:Nitroprusside / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D012756:Sheep; D012769:Shock / Q000188:drug therapy*; D013552:Swine; D013566:Sympathomimetics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D003486:Cyanides; D005292:Ferricyanides; D013566:Sympathomimetics; D014665:Vasodilator Agents; D009599:Nitroprusside
Natriev nitroprusid pri tsentraliziran shok na krŭvoobrashtenieto.